VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 42
Summary
- Conditions
- Parkinson's Disease
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Randomized, Sham Surgery Controlled, Double-blind, Multi-centerMasking: Triple (Participant, Care Provider, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 75 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03562494
- Collaborators
- Voyager Therapeutics
- Investigators
- Study Director: Grace Liang, MD Neurocrocrine Biosciences
Get Well Soon